ArticleClinical cardiology2026
A Comparative Analysis of Short-Term Outcomes of Off Pump Coronary Artery Bypass Grafting Alone or Simultaneous Cerebral Revascularization: A Single-Center Retrospective Study.
Article in Clinical cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectivesThe impact of simultaneous coronary artery bypass grafting (CABG) with cerebral revascularization versus CABG alone on perioperative complications and short-term outcomes remains controversial in patients with simultaneous coronary and cerebrovascular disease. Our study was specifically designed to evaluate the effects of simultaneous cardio-cerebrovascular revascularization versus isolated off-pump CABG (OPCABG) in patients with severe carotid stenosis.
methodsThis retrospective analysis included patients undergoing OPCABG between May 2023 and May 2025. Participants were divided into two groups based on simultaneous carotid revascularization status, including the combined cardio-cerebrovascular revascularization group (n = 57) and the isolated OPCABG control group (n = 60). The primary endpoints comprised 30-day mortality and all-cause mortality during follow-up. Cardiac, hepatic, and renal function biomarkers were monitored daily for three consecutive postoperative days. Kaplan-Meier analysis demonstrated the survival probability of patients undergoing different surgical procedures throughout the follow-up period.
resultsOur study with a median follow-up of 11.5 months (IQR: 6.8-20.0 months) observed a lower short-term mortality rate of 5.3% (3/57) in the combined cardio-cerebrovascular revascularization group. Our results demonstrated no significant differences in 30-day mortality and all-cause mortality during follow-up between the combined cardio-cerebrovascular intervention and isolated OPCABG. No intergroup differences were observed in cardiac, hepatic, or renal function within the first three postoperative days. The combined surgical approach reduced hospitalization duration.
conclusionOur findings demonstrated comparable short-term outcomes between patients receiving simultaneous cardio-cerebrovascular revascularization and those undergoing isolated CABG. This simultaneous intervention represents a clinically meaningful advancement in managing systemic vasculopathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.